Threshold Pharmaceuticals, Inc (THLD): Opiniones

THLD
Datos actualizados Fase II SARCOMA

http://www.equities.com/news/headline-story?dt=2012-11-15&val=717465&cat=hcare

a estudiar señores, a estudarlos!

"We are pleased with these results suggesting that TH-302 can be combined with doxorubicin and continued as single agent maintenance treatment for patients with soft tissue sarcoma," said Tillman Pearce, M.D., Chief Medical Officer of Threshold. "These results support our ongoing Phase 3 clinical trial evaluating the potential efficacy and safety of TH-302 plus doxorubicin in extending the lives of patients with soft tissue sarcoma."

TH-302 has been granted Orphan Drug Designation in the U.S. and Europe for the treatment of soft tissue sarcoma.

Stop! Nuevos resultados del TH-302 y Doxorubicin en tejidos blandos (Sarcoma)

http://investor.thresholdpharm.com/releasedetail.cfm?ReleaseID=721505

De todo me quedo con esto:
"We are pleased with these results suggesting that TH-302 can be combined with doxorubicin and continued as single agent maintenance treatment for patients with soft tissue sarcoma," said Tillman Pearce, M.D., Chief Medical Officer of Threshold. "These results support our ongoing Phase 3 clinical trial evaluating the potential efficacy and safety of TH-302 plus doxorubicin in extending the lives of patients with soft tissue sarcoma."

A ver si es suficiente para detener la sangría y que vuelva el interés comprador a THLD

quedate tambien con lo que habia puesto al final:
concedido medicamento huerfano en europa.

eso es pasta y subvenciones

http://www.nasdaq.com/symbol/thld/premarket
4.40
Volumen: Yo solo llevo más acciones y soy un matao.
Seamos realistas !

Asi es @framus, pero eso no era ya conocido? ¿o solo era en USA?

TH-302 has been granted Orphan Drug Designation in the U.S. and Europe for the treatment of soft tissue sarcoma

http://www.equities.com/news/headline-story?dt=2012-11-14&val=712772&cat=hcare

http://www.rttnews.com/2007177/threshold-issues-updated-results-from-phase-2-study-of-th-302-quick-facts.aspx?type=qf&utm_source=google&utm_campaign=sitemap

Aquí en su web está como siempre la conferencia de ayer entera

http://investor.thresholdpharm.com/events.cfm

He estado mirando por ahi. Creo que tienes razon. Yo pensaba que tenian solo USA.
Tengo que empezar a apuntar las cosas que se me va la olla